GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
205 hedge funds and large institutions have $1.89B invested in Global Blood Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
205
Holders Change
+18
Holders Change %
+9.63%
% of All Funds
3.17%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.11%
New
51
Increased
61
Reduced
64
Closed
30
Calls
$13.1M
Puts
$8.9M
Net Calls
+$4.25M
Net Calls Change
-$31.8M
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$5.37M |
| 2 |
Franklin Resources
San Mateo,
California
|
$17.9M |
| 3 |
PA
Perceptive Advisors
New York
|
$101M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
$160M |
| 5 |
CC
Casdin Capital
New York
|
$38.8M |
